Enveric Biosciences, Inc. (ENVB)

1.37 0.00 (0.00%) USD  |  NASDAQ  |  Aug 28, 16:00
1.37 0.00 (0.00%) After-Hours: 20:00
More

Enveric Biosciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2022. Start Trial.
Date Value
August 01, 2024 --
April 02, 2024 --
January 30, 2024 --
December 29, 2023 --
November 20, 2023 --
October 03, 2023 --
Date Value
August 24, 2023 --
September 05, 2022 --
May 26, 2022 --
March 08, 2022 --
February 02, 2022 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
LENZ Therapeutics, Inc. Upgrade
Impact BioMedical, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade